16 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptides.

Nih
New HIV-1 reverse transcriptase inhibitors based on a tricyclic benzothiophene scaffold: synthesis, resolution, and inhibitory activity.

Nih
Application of azide-alkyne cycloaddition 'click chemistry' for the synthesis of Grb2 SH2 domain-binding macrocycles.

Nih
Synthesis of tripeptides as potent Yersinia protein tyrosine phosphatase inhibitors.

Nih
Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic.

Nih
Design and synthesis of dimeric HIV-1 integrase inhibitory peptides.

Nih
Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration.

Nih
Bicyclic-fused heteroaryl or aryl compounds

Pfizer
Substituted pyrrolidines as mGluR5 antagonists

Hua Medicine (Shanghai)
NMDA receptor modulators and uses related thereto

Emory University
Compounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof

Handok
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors

Array Biopharma
HIV-1 reverse transcriptase structure with RNase H inhibitor dihydroxy benzoyl naphthyl hydrazone bound at a novel site.

Rutgers University
Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]-4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes.

Abbott Laboratories
Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysis.

Dupont Pharmaceuticals
Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors.

Dupont Pharmaceuticals